- Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial
-
Kang K, Han S, Hong T, Jeon S, Paek J, Kang JH, Yim DS
- KMID: 2427152
- Yonsei Med J.
- 2016 Nov;57(6):1354-1360.
- doi: 10.3349/ymj.2016.57.6.1354
PURPOSE: A phase I clinical trial was conducted to evaluate the immunogenicity and safety of newly developed egg-cultivated trivalent inactivated split influenza vaccine (TIV) in Korea. MATERIALS AND METHODS: The TIV... -
- CITED
-
- Close
- SHARE
-
- Close
- Immunogenicity and Safety of Trivalent Inactivated Influenza Vaccine: A Randomized, Double-Blind, Multi-Center, Phase 3 Clinical Trial in a Vaccine-Limited Country
-
Song JY, Cheong HJ, Woo HJ, Wie SH, Lee JS, Chung MH, Kim YR, Jung SI, Park KH, Kim TH, Uh ST, Kim WJ
- KMID: 1782105
- J Korean Med Sci.
- 2011 Feb;26(2):191-195.
- doi: 10.3346/jkms.2011.26.2.191
Influenza vaccines are the primary method for controlling influenza and its complications. This study was conducted as a phase 3, randomized, double-blind, controlled, multi-center trial at seven university hospitals to... -
- CITED
-
- Close
- SHARE
-
- Close
